Table 2 Adverse events for all patients
Adverse events | Age >75 years (n = 32) | Age ≤75 years (n = 39) | p value |
|---|---|---|---|
Dyspahgia (CTCAE) | 0.132 | ||
0° (%) | 0.0 | 15.4 | |
I° (%) | 50.0 | 43.6 | |
II° (%) | 28.1 | 20.5 | |
III° (%) | 21.9 | 17.9 | |
IV (%) | 0.0 | 2.6 | |
Leukopenia (CTCAE) | 0.105 | ||
0° (%) | 34.4 | 26.3 | |
I° (%) | 18.7 | 18.4 | |
II° (%) | 37.5 | 26.3 | |
III° (%) | 6.3 | 29.0 | |
IV (%) | 3.1 | 0.0 | |
Anemia (CTCAE) | 0.157 | ||
0° (%) | 3.1 | 17.9 | |
I° (%) | 56.3 | 38.5 | |
II° (%) | 37.5 | 41.0 | |
III° (%) | 3.1 | 2.6 | |
Thrombocytopenia (CTCAE) | 0.795 | ||
0° (%) | 31.3 | 34.3 | |
I° (%) | 50.0 | 51.4 | |
II° (%) | 18.7 | 11.4 | |
III° (%) | 0.0 | 0.0 | |
IV (%) | 0.0 | 2.9 | |